NewcelX (NCEL) Current Leases (2022 - 2024)
NewcelX (NCEL) posted Current Leases of $144,000 for Q2 2024, down 66.4% from $429,000 a year earlier.
Powered by 
Analysis
NewcelX (NCEL) Current Leases (2022 - 2024) Analysis & Trends
At the end of FY2023, NewcelX's Current Leases came in at $361,000, down 9.1% from FY2022.
- In prior years, NewcelX's Current Leases was $397,000 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | - |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | - |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | - |
| 10 | NewcelX | 10.92 Mn | 4.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 144,000.00 |
| Dec 31, 2023 | 361,000.00 |
| Jun 30, 2023 | 429,000.00 |
| Dec 31, 2022 | 397,000.00 |
API Access
NewcelX Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=NCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "NCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=NCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();